7Baggers
Quarterly
Annual
    Unit: USD2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                  
      cash flows from operating activities:
    		                  
      net income
    		-9,089,000 -9,964,000 -57,845,000 -11,674,000 -15,837,000 -13,172,000 -7,293,000 -11,859,000 -4,487,000 -10,358,000 -4,526,000 -5,333,000 -8,128,000 -8,823,000 -560,733 -114,030 -247,272 -164,103 
      adjustments to reconcile net income to net cash from operating activities:
    		                  
      depreciation and amortization
    		4,513,000 4,435,000 5,952,000 5,719,000 5,936,000 5,902,000 6,028,000 5,516,000 2,551,000 909,000 866,000 638,000 631,000 638,000     
      stock-based compensation
    		1,973,000 2,013,000 1,464,000 4,457,000 8,490,000 6,759,000             
      write off of property and equipment
    		                  
      impairment of intangible assets
    		                  
      non-cash reduction to the right-of-use asset
    		-14,000 10,000                 
      benefit from doubtful accounts
    		1,660,000 2,503,000 901,000 495,000 749,000 176,000  -16,000 -5,000 813,000         
      realized gains on marketable securities
    		8,000 8,000 7,000 6,000 4,000 5,000 13,000 -4,000 23,000 -2,000         
      employee benefit obligation
    		182,000 144,000 -385,000 134,000 238,000 514,000 293,000 122,000 53,000 69,000 151,000 123,000 164,000 89,000     
      change in fair value of warrant liability
    		14,000 12,000 -14,000 -39,000 -276,000 -534,000 -118,000 -166,000 -433,000 1,263,000         
      non-cash interest expense
    		562,000 528,000 551,000 483,000 524,000 490,000 509,000 420,000 210,000 115,000 40,000 34,000 45,000 72,000     
      deferred taxes
    		  -5,589,000 524,000 -644,000 820,000 -1,180,000 -68,000 -7,467,000 663,000 -1,849,000 -262,000 -313,000 -323,000     
      change in operating assets and liabilities:
    		                  
      trade receivables
    		7,658,000 481,000 28,000 7,374,000 -16,329,000 3,010,000 -4,144,000 -5,476,000 -7,699,000 440,000 -1,399,000 128,000 -917,000 1,710,000     
      other current assets
    		-488,000 -275,000 -1,790,000 170,000 412,000 1,504,000 287,000 -324,000 -2,195,000 -164,000 -687,000 -54,000 827,000 1,111,000     
      deferred cost
    		-20,000 -15,000 28,000 -18,000 -10,000 22,000             
      operating lease liability
    		-1,000 3,000                 
      other long-term assets
    		-222,000 -542,000 287,000 -264,000 -113,000 -1,074,000 -5,000 -62,000 -16,000 1,499,000 -10,000 -39,000 360,000 -808,000     
      accounts payable
    		-7,328,000 -2,614,000 3,199,000 6,316,000 6,177,000 -816,000 -2,889,000 6,679,000 2,246,000 -4,128,000 1,895,000 -8,352,000 319,000 -5,694,000 116,262 54,923 -20,833 1,176,790 
      other current liabilities
    		-4,316,000 6,399,000 -2,477,000 4,217,000 -656,000 2,334,000 722,000 3,921,000 227,000 -2,735,000 3,429,000 -1,596,000 1,533,000 3,526,000 -115,949 -28,740 17,219 -7,326 
      deferred revenue
    		-848,000 -276,000 -1,957,000 -1,429,000 319,000 -2,708,000 -1,442,000 131,000 7,394,000 -474,000 2,067,000 -19,000 -35,000 206,000     
      long-term liabilities
    		137,000 -397,000 370,000 -33,000 -47,000 -40,000 -49,000 521,000 -64,000 -18,000 -1,314,000 117,000 -807,000 1,505,000     
      net cash from operating activities
    		-5,078,000 2,453,000 -7,877,000 16,438,000 -11,063,000 3,192,000 -4,015,000 5,196,000 -4,906,000 -8,207,000 1,692,000 -9,593,000 -1,569,000 -2,852,000 -338,937 -516,459 -602,542 -495,083 
      capex
    		-2,150,000 -2,037,000 -1,923,000 -2,854,000 -2,592,000 -2,876,000 -3,093,000 -2,180,000 -951,000 -859,000 -378,000 -1,178,000 -1,045,000 -820,000 0 0 0 0 
      free cash flows
    		-7,228,000 416,000 -9,800,000 13,584,000 -13,655,000 316,000 -7,108,000 3,016,000 -5,857,000 -9,066,000 1,314,000 -10,771,000 -2,614,000 -3,672,000 -338,937 -516,459 -602,542 -495,083 
      cash flows from investing activities:
    		                  
      purchase of short-term investments
    		0 -46,000 0 0 0 -1,165,000 0 -50,342,000   4,000 -2,997,000 -1,741,000 -3,179,000     
      sale of short-term investments
    		  26,000 36,000   30,195,000 20,000,000 0 546,000 341,000 2,774,000 0 5,041,000     
      purchase of property and equipment
    		-657,000 -231,000 -343,000 -792,000 -422,000 -544,000 -1,015,000 -665,000 -86,000 -91,000 555,000 -475,000 -405,000 -89,000     
      capitalized software development costs
    		-1,493,000 -1,806,000 -1,580,000 -2,062,000 -2,170,000 -2,332,000 -2,078,000 -1,515,000 -865,000 -768,000 -933,000 -703,000 -640,000 -731,000     
      purchase of intangible assets
    		  0 0   -7,000 -21,000 -1,000 -2,000 0 0 0 -6,000     
      acquisition of bandyer, net of cash acquired
    		  0 0 -1,063,000 58,000 0            
      net cash from investing activities
    		-2,142,000 -2,083,000 -1,897,000 -2,818,000 2,787,000 -3,983,000 27,095,000 -45,484,000 -198,543,000 -315,000 -33,000 -1,401,000 -2,786,000 1,052,000 -496,928 70,252,117 -1,021,911 222,115 
      cash flows from financing activities:
    		                  
      proceeds from (repayments on) line of credit
    		475,000 -1,014,000 380,000 279,000    237,000           
      repayments on term loans
    		-3,052,000 -3,340,000 -2,286,000 -2,391,000 -2,359,000 -2,134,000 -2,854,000 -1,423,000 -1,582,000 -1,869,000 -2,307,000 -603,000 -278,000 -5,463,000     
      repayments on notes
    		      0 0 -3,750,000 -3,750,000         
      repayments on capital lease
    		-50,000 -48,000 -183,000 -13,000 -17,000 -29,000 -35,000 -37,000 -29,000 -37,000         
      net cash from financing activities
    		-3,032,000 -4,402,000 -2,089,000 394,000 -3,627,000 -2,688,000 -3,001,000 -5,429,000 286,065,000 11,970,000 -1,906,000 4,857,000 4,472,000 2,304,000 976,327 -69,543,760   
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-244,000 902,000  -1,129,000 -1,896,000 -334,000  -867,000 502,000 -911,000  403,000 84,000 -454,000     
      net decrease in cash, cash equivalents and restricted cash
    		-10,496,000 -3,130,000                 
      cash, cash equivalents and restricted cash, beginning of period
    		0 77,980,000 0 0 0 91,702,000   0 32,970,000 0 0 0 36,997,000     
      cash, cash equivalents and restricted cash, end of period
    		-10,496,000 74,850,000 -8,995,000 12,885,000 -13,799,000 87,889,000   83,118,000 35,507,000 1,456,000 -5,734,000 201,000 37,047,000     
      supplemental disclosures of cash flow information:
    		                  
      cash paid for interest
    		6,428,000 351,000   6,287,000 173,000    368,000 221,000 289,000 295,000 153,000     
      cash paid for income taxes
    		                  
      non-cash investing and financing activities
    		                  
      restricted stock units granted to employees for bonuses
    		                  
      consideration payable
    		0 488,000                 
      adoption of asc 326
    		0 -1,270,000                 
      reversal of accrued interest on forward share purchase agreement
    		      0 0 0 -659,000         
      acquisition of mgage, net of cash acquired
    		      0 363,000           
      borrowings on term loans
    		  0    0    -1,000 15,637,000 0 8,800,000     
      proceeds from issuance of convertible notes, net of issuance costs
    		      0 0           
      receipts related to forward share purchase agreements
    		                  
      proceeds from issuance of common stock in private investment in public equity offering (pipe), net of issuance costs
    		      0            
      proceeds related to settlement of non-forfeited 2020 sponsor earnout shares
    		      0 0 0 1,244,000         
      proceeds from exercise of common stock warrants
    		                  
      repurchase of warrants
    		      0            
      effect of exchange rate changes on cash, cash equivalent and restricted cash
    		                  
      net increase in cash, cash equivalents and restricted cash
    		  -8,995,000 12,885,000 -13,799,000 -3,813,000   83,118,000 2,537,000 1,456,000 -5,734,000 201,000 50,000     
      supplemental disclosure of cash flow information:
    		                  
      non-cash investing and financing activities:
    		                  
      change in value of forward share purchase agreements
    		         -483,000 3,000 0 -1,942,000 271,000     
      common stock issued to vivial equity holders
    		                  
      stock-based compensation related to capitalized software development costs
    		                  
      conversion of convertible note to common stock
    		                  
      fair value of warrant liability
    		                  
      asset acquired under capital leases
    		                  
      initial recognition of the lease at commencement
    		                  
      proceeds from issuance of common stock in private investment in public equity offering, net of issuance costs
    		                  
      proceeds from the exercise of common stock warrants
    		       0           
      repayments on line of credit
    		     -525,000             
      stock-based compensation capitalized as software development costs
    		                  
      receivable for proceeds from the exercise of warrants
    		                  
      stock-based compensation, preference shares and others
    		      4,901,000 5,820,000 4,710,000 4,560,000         
      non-cash settlement of preference share liability
    		          0 0 0 -2,486,000     
      benefit from (recovery of) doubtful accounts
    		                  
      sale of property and equipment
    		          0 0 0 16,000     
      proceeds from line of credit
    		                  
      repurchase of common stock in connection with forward share purchase agreements
    		          0 -6,213,000 -21,631,000 -2,587,000     
      receipts (payments) related to forward share purchase agreements
    		      0 0 0 17,045,000         
      proceeds from issuance of stock in public offering, net of issuance costs
    		          0 3,472,000       
      common stock issued to settle payables
    		                  
      note payable issued to settle payables
    		                  
      deferred costs
    		       41,000           
      proceeds from issuance of common stock in public offering, net of issuance costs
    		                  
      proceeds from (repayments on) in line of credit
    		         -663,000         
      common stock issued to settle a payable
    		           0 2,700,000 423,000     
      note payable issued to settle a payable
    		           0 2,700,000 400,000     
      cash, cash equivalents and restricted cash acquired in the reverse merger
    		                  
      payments of deferred consideration for the acquisition of buc mobile
    		                  
      payments of deferred consideration for the acquisition of solutions infini
    		                  
      change in line of credit
    		          528,000 -604,000 -368,000 1,721,000     
      payments related to forward share purchase agreements
    		          0 -832,000 -453,000 -167,000     
      stock-based compensation, preference share and unpaid bonuses
    		           4,922,000       
      allowance for doubtful accounts
    		           100,000 -73,000 117,000     
      payment of deferred consideration for the acquisition of buc mobile
    		                  
      payment of deferred consideration for the acquisition of solutions infini
    		                  
      repayments on notes payable
    		           -6,000,000       
      non-cash financing activities:
    		                  
      issuance costs for public offering included in accounts payable
    		                  
      stock-based compensation and preference share liability
    		             6,308,000     
      stock-based compensation and preference shares
    		                  
      loss on equity investments
    		                  
      purchases of marketable securities
    		                  
      sales of marketable securities
    		                  
      purchases of property and equipment
    		                  
      sales of property and equipment
    		                  
      purchases of intangible assets
    		                  
      acquisition of buc mobile, net of cash acquired
    		                  
      acquisition of solutions infini, net of cash acquired
    		                  
      payment of deferred consideration in relation to the acquisition of buc mobile
    		                  
      payment of deferred consideration in relation to the acquisition of solutions infini
    		                  
      borrowings on term loan
    		                  
      repayments on term loan
    		                  
      proceeds from exercise of stock options
    		                  
      cash, cash equivalents and restricted cash at beginning of year
    		                  
      cash, cash equivalents and restricted cash at end of year
    		                  
      supplemental disclosures of other cash flow information:
    		                  
      operating activities
    		                  
      interest earned on cash and marketable securities held in trust account
    		              -422,455 -612,480 -786,533 -706,074 
      interest receivable on cash and marketable securities held in trust account
    		              35,038 -96,095 -18,359 -41,112 
      receivable from related party
    		              0 -6,946 4,063 2,166 
      prepaid expenses
    		              20,520 13,854 47,187 17,416 
      payable to related party
    		              79,302 24,197   
      accrued liabilities
    		              509,078 248,858 382,064 -772,840 
      investing activities
    		                  
      investment of cash in trust account
    		              -720,000 -240,000   
      interest income used to pay taxes
    		              223,072    
      cash withdrawn from trust account
    		              0 69,542,655 415,589 222,115 
      financing activities
    		                  
      proceeds from sale of units, net of underwriting discounts paid
    		                  
      proceeds from sale of private placement units
    		                  
      proceeds from the sale of founder shares
    		                  
      redemption of public shares
    		                  
      notes payable to founders
    		                  
      repayment of notes payable to founders
    		                  
      payment of deferred offering costs
    		                  
      net change in cash and cash equivalents
    		              140,462 191,898 -186,953 -272,968 
      cash and cash equivalents, beginning of period
    		              0 0 0 597,268 
      cash and cash equivalents, end of period
    		              140,462 191,898 -186,953 324,300 
      supplemental disclosure of noncash investing activities
    		                  
      change in value of common stock subject to possible redemption
    		              -1,611,550 936,780 -247,272 -164,103 
      proceeds from sale of private placement shares
    		                  
      promissory notes from related parties
    		                  
      repayment of promissory notes from related parties
    		                  
      redemption of common stock
    		                  
      promissory notes issued in conjunction with extension
    		                  
      promissory notes for extension
    		                  
      restricted cash
    		                  
      interest earned on marketable securities held in trust account
    		                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.